Bill & Melinda Gates Foundation — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Infinant Healthinfinanthealth.comin 𝕏May 2026

Infinant Health develops a B. infantis probiotic pharmaceutical product (INF108, building on EVC001) aimed at preventing necrotizing enterocolitis (NEC) in preterm and very low birth weight infants in NICU care.

BiotechDigital HealthHealthtechWellness & FitnessSacramento, US

Michael Johnson(Executive Officer, Director)J. Bruce German(Co-founder)David Mills(Co-founder)Carlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.